Coloplast A/S
(XSWX:COLOB)
CHF
115
0 (0%)
Market Cap: 22.64 Bil
Enterprise Value: 25.50 Bil
PE Ratio: 40.61
PB Ratio: 11.45
GF Score: 91/100 
Coloplast A/S at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 14, 2021 / 04:40PM GMT
Release Date Price:
CHF111
David James Adlington
JPMorgan Chase & Co, Research Division - Head of Medical Technology and Services Equity Research
Good morning, everybody. Welcome. It's David Adlington again from the JPMorgan med tech team in Europe. It's my pleasure to introduce CEO of Coloplast, Kristian Villumsen, for this latest session. (Operator Instructions)
Kristian, thanks for joining us today, and over to you for the presentation.
Kristian Villumsen;S;President;CEO
Coloplast A
/-&
Thank you very much, David. Can I just check that you hear me loud and clear?
David James Adlington
JPMorgan Chase & Co, Research Division - Head of Medical Technology and Services Equity Research
Yes. Perfect.
Kristian Villumsen;S;President;CEO
Coloplast A
/-&
Very good. So I'll speak for about 20 minutes for the benefit of the people participating who may not know the company so well. And
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers